Persistence of uncontrolled hypertension post-cardiac rehabilitation in stable coronary patients

Thierry Denolle1, Claude Pellen2, Anne Laure Serandour2

  • 1Rivarance Network, Arthur Gardiner Hospital Dinard, Dinard, France. denolle.thierry@wanadoo.fr.

Insights

Hypertension management in stable coronary heart disease patients often fails long-term post-cardiac rehabilitation. Key factors include reduced beta-blockade, physician inertia, and guideline non-adherence, leading to uncontrolled blood pressure.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Clinical Pharmacy

Background:

  • Uncontrolled cardiovascular risk factors, particularly hypertension, are linked to myocardial infarction in stable coronary heart disease.
  • Effective management of hypertension is crucial for secondary prevention in these patients.

Purpose of the Study:

  • To analyze the long-term management and control of hypertension in stable coronary heart disease patients following cardiac rehabilitation.
  • To identify factors contributing to the lack of sustained blood pressure control one year after cardiac rehabilitation.

Main Methods:

  • Prospective study of 746 stable coronary patients (2005-2015).
  • Documentation of risk factors and pharmacological treatments pre-, immediately post-, and 1-year post-cardiac rehabilitation.
  • Analysis of blood pressure control rates and contributing factors to hypertension recurrence.

Main Results:

  • While other risk factors improved, hypertension control remained poor one year post-cardiac rehabilitation (49% controlled vs. 20% or 10% by guidelines).
  • 42% of patients achieving normotension post-rehabilitation had uncontrolled hypertension at 1 year, with increased weight and decreased physical activity/antihypertensive use.
  • Factors associated with elevated blood pressure included beta-blockade discontinuation (+7.9 mmHg), age >65 (+6.2 mmHg), and diabetes mellitus (+7.6 mmHg).
  • Only 48% received guideline-recommended antihypertensive polytherapy, and 61% of prescriptions were not adjusted post-rehabilitation.

Conclusions:

  • Hypertension is the only cardiovascular risk factor that does not improve one year post-cardiac rehabilitation.
  • Reasons for persistent uncontrolled hypertension include reduced beta-blockade, physician inertia, and poor adherence to international guidelines.
  • Optimizing hypertension management requires sustained pharmacological treatment adjustments and adherence to evidence-based guidelines.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
91
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
645
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
169
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
116
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
112